How we rank compounded GLP-1 providers

The short version: We score each compounded GLP-1 provider from 0 to 10 on five weighted criteria — pricing transparency (25%), pharmacy disclosure (25%), review score and volume (20%), clinical oversight (15%), and support and guarantee (15%). The weights total 100%. The same rubric is applied to every provider, including MaxLife, our #1-ranked pick and a provider we earn referral commissions from.

The five criteria and their weights

The two most heavily weighted criteria — pricing transparency and pharmacy disclosure — together account for 50% of the total score. We weight them highest because they are the two things a patient can least easily verify on their own and the two that most directly affect cost and safety with compounded medication, which is not FDA-approved.

Why pricing transparency is weighted at 25%

Compounded GLP-1 pricing is notoriously hard to compare. Some providers advertise a low headline figure, then add a separate monthly membership; Mochi Health, for example, lists compounded semaglutide at $99/month plus a $79/month membership. Others gate the real number behind an intake quiz and add roughly $100/month for higher doses, as several reviewers report of Henry Meds. A provider that publishes one flat, all-in price — consultation, medication, and shipping included — is easier to trust and easier to budget for, so it scores highest here.

Why pharmacy disclosure is weighted at 25%

Because compounded semaglutide and tirzepatide are not FDA-approved, the compounding pharmacy is the single most important quality signal. A provider that names its pharmacy partner lets you check that pharmacy's licensing, accreditation, and inspection history yourself. In our current field, several providers — including Mochi and TrimRx — do not publicly name their current compounding pharmacy, while Henry Meds names Hallandale Pharmacy. We explain how to vet a pharmacy in our guide on how to verify a compounding pharmacy.

Reviews, clinical oversight, support

For reviews, both the rating and its volume matter: a 4.5 built on ~12,500 reviews carries different weight than a 4.4 on ~239, and a listing that a platform has flagged for suspected incentivized reviews is discounted rather than taken at face value. Clinical oversight rewards live video visits, dietitian access, and lab work over a bare async questionnaire. Support and guarantee rewards responsive service and clear, honored refund terms.

How scores are calculated

Each provider earns a 0–10 sub-score on every criterion. We multiply each sub-score by its weight and sum the results to produce the overall score out of 10 shown in our rankings. Because the weights are fixed and public, a provider cannot rank higher by our simply preferring it — the ranking has to be justified by the data. If a provider's placement cannot be explained by this rubric, we fix the ranking or the rubric, never the data.

Where our data comes from

MaxLife's figures are confirmed from its internal Google Merchant Center feed and its Trustpilot profile. Competitor figures are sourced from each provider's own published pricing pages and public listings on Trustpilot, the Better Business Bureau, and reputable third-party reviews, with regulatory items drawn from court dockets, FDA notices, and news reporting. We label competitor figures as sourced in June 2026 and mark them "verify live," because most provider pricing pages block automated access and review counts move constantly.

Where a specific value has not been confirmed to our standard, we show a visible placeholder rather than guess. We do not publish invented reviews, ratings, prices, patients, or providers under any circumstances.

How often we refresh

We aim to re-verify pricing and review figures at least every 30 to 45 days, and sooner when a provider announces a pricing change or a material regulatory event occurs. Each page carries a visible "last updated" date, and the date is also encoded in the page's structured data. This page was last updated on July 3, 2026.

On independence and conflicts of interest

We want to be direct about this: The GLP-1 Guide is not an impartial publication, and we never describe it that way. It is published by Generation Health, LLC, which is not owned by MaxLife but is affiliate-supported — we earn referral commissions when readers enroll with providers we feature, including MaxLife, our #1-ranked pick. What we can offer instead is a fixed, published rubric applied identically to every provider, real sourced data, and honest pros and cons for each option — including MaxLife. You can weigh our rankings with that financial interest in full view.